Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

IGF inhibition with xentuzumab prior to radical prostatectomy

 

WINGMEN Logo

Full Title

Windows trial of INsulin-like Growth factor neutralising antibody Xentuzumab in MEN scheduled for radical prostatectomy

Chief Investigator: Dr Simon Lord

Sponsor: University of Oxford

 

STATUS

Protocol currently under development.